Amcor drops as recent downgrades spotlight weak volumes despite Berry synergy progress
Amcor (AMCR) is sliding after a string of recent analyst downgrades that cut price targets and highlighted weak organic volume momentum. The latest calls shift focus to integration execution after the Berry deal, with investors de-risking ahead of the next earnings update.
1. What’s moving the stock
Amcor shares are under pressure today as investors react to a negative shift in analyst sentiment over the past two weeks, centered on soft organic volume trends and reduced upside expectations even as merger integration remains on track. Morgan Stanley recently downgraded AMCR to Equal Weight and cut its price target to $46 from $57.50, citing negative organic volume momentum despite Berry-related synergies and valuation appeal. (tipranks.com)
2. The latest analyst catalyst
Selling pressure has also been reinforced by Wells Fargo’s March 20, 2026 downgrade to Equal Weight from Overweight, along with a price-target cut to $43 from $48. That downgrade is being treated as a near-term valuation reset for a defensive packaging name that had been bid up on post-merger synergy expectations. (insidermonkey.com)
3. What investors are watching next
The key debate is whether Amcor can re-accelerate volumes while holding the line on fiscal 2026 profitability and cash generation. Amcor’s most recent quarterly update (fiscal 2Q26) showed adjusted EPS of $0.86 and reaffirmed fiscal 2026 guidance, which keeps the focus on execution and whether demand improves enough to close the gap highlighted by the downgrades. (assets.ctfassets.net)